EUVIMEDEUVIMED entdecken
Crossref

Mechanism of Sanhua Decoction Against Cerebral Ischemia–Reperfusion Injury by Serum Pharmacochemistry, Network Pharmacology, and Metabolomics

Tingting Liu, Lijun An, Xue-Li Song, Guo Feng, Qian Qin, Caiyao Han, Yan Lei iD, Gang Liu, Kexin Ma, Jinxin Hou, Wei Li, Yi Sui und 2 weitere

Biomedical Chromatography · 2026

DOI: 10.1002/bmc.70339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Tingting Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chinese Materia Medica, Guizhou University of Traditional Chinese Medicine, Guiyang, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Reperfusion Injury, Brain Ischemia, Metabolome. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Guiyang College of TCM Doctor Startup Fund Project, National Training Program for Innovative Backbone Talents for TCM, "Thousand" level Innovative Talents Project in Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral ischemia–reperfusion injury (CIRI) is classified under the category of stroke. Sanhua Decoction (SHD) is a classic prescription for the treatment of stroke, but its pharmacodynamic material basis and mechanism of action have not been fully elucidated. This study aimed to elucidate the bioactive components and therapeutic mechanisms of SHD against CIRI by integrating serum pharmacochemistry, network pharmacology, and metabolomics. Using ultra‐high‐performance liquid chromatography coupled with quadrupole time‐of‐flight tandem mass spectrometry, a 22 absorbed SHD prototype compounds were identified from rat serum. Through the application of network pharmacology and molecular docking technology, it was concluded that the key active ingredients, such as marmesin and aloe‐emodin, mainly play a therapeutic role through key targets such as steroid receptor coactivator (SRC) and protein kinase B1 (AKT1). Molecular docking showed that these targets had strong affinity with key compounds. The results of pharmacodynamics showed that SHD could improve the neurological function score of CIRI rats, reduce the infarct area, and improve the pathological changes of brain tissue. Metabolomics analysis showed that SHD may play a therapeutic role by regulating steroid hormone synthesis and ubiquinone‐related pathways. This study provides a methodological framework for exploring the role of Chinese herbal compounds in the treatment of CIRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalReperfusion InjuryBrain IschemiaMetabolomeAnimalsMetabolomicsNetwork PharmacologyRatsMaleMolecular Docking SimulationRats, Sprague-DawleyChromatography, High Pressure LiquidTandem Mass SpectrometryDisease Models, AnimalBrain

Stichwörter der Autor:innen

Sanhua Decoctioncerebral ischemia–reperfusion injurymaterial basismetabolomicsnetwork pharmacologyserum pharmacochemistry

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Chinese Materia Medica, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  • NMPA Key Laboratory for Bioequivalence Research of Generic Drug Evaluation, NMPA Key Laboratory for Quality Research and Evaluation of Traditional Chinese Medicine, Shenzhen Institute for Drug Control, Shenzhen, China.
  • Guizhou Inheritance Base of Traditional Chinese Medicine Processing Technology, Guizhou, China.

ORCID-Profile: Yan Lei

Förderung

  • Guiyang College of TCM Doctor Startup Fund Project
  • National Training Program for Innovative Backbone Talents for TCM
  • "Thousand" level Innovative Talents Project in Guizhou Province
  • "Construction of Traditional Chinese Medicine Processing Technology Inheritance Base" Project of the State Administration of Traditional Chinese Medicine
  • Guizhou University of Traditional Chinese Medicine ("Thousand level" Talent) Research Project
  • Guizhou Traditional Chinese Medicine Processing Technology Inheritance Base Construction Project
  • Central-Level Major Increase or Decrease Expenditure Projects
  • National and Provincial Science and Technology Innovation Talent Team Cultivation Project of Guizhou University of Traditional Chinese Medicine

Zitieren

APA

Liu, T., An, L., Song, X. L., Feng, G., Qin, Q., Han, C., Lei, Y., Liu, G., Ma, K., Hou, J., Li, W., Sui, Y., Li, B., & Wang, B. (2026). Mechanism of Sanhua Decoction Against Cerebral Ischemia–Reperfusion Injury by Serum Pharmacochemistry, Network Pharmacology, and Metabolomics. Biomedical Chromatography. https://doi.org/10.1002/bmc.70339

Vancouver

Liu T, An L, Song XL, Feng G, Qin Q, Han C, et al. Mechanism of Sanhua Decoction Against Cerebral Ischemia–Reperfusion Injury by Serum Pharmacochemistry, Network Pharmacology, and Metabolomics. Biomedical Chromatography. 2026. doi:10.1002/bmc.70339

BibTeX
@article{Liu2026,
  author = {Liu, Tingting and An, Lijun and Song, Xue-Li and Feng, Guo and Qin, Qian and Han, Caiyao and Lei, Yan and Liu, Gang and Ma, Kexin and Hou, Jinxin and Li, Wei and Sui, Yi and Li, Bing and Wang, Bing},
  title = {Mechanism of Sanhua Decoction Against Cerebral Ischemia–Reperfusion Injury by Serum Pharmacochemistry, Network Pharmacology, and Metabolomics},
  journal = {Biomedical Chromatography},
  year = {2026},
  doi = {10.1002/bmc.70339}
}
Kostenlos starten →